Skip to content
Search

Latest Stories

UK Covid-19 death toll rises to nearly 50,000

The UK’s Covid-19 death toll neared 50,000 on Tuesday (2), confirming its place as one of the worst hit countries in the world just as prime minister Boris Johnson tries to ease the stringent novel coronavirus outbreak.

The toll now stands at 49,646, including death certificate data for England and Wales released on Tuesday up to May 22, previously published figures for Scotland and Northern Ireland, and recent hospital deaths in England.


Such a large death toll has prompted criticism of Johnson, who opposition parties say was too slow to impose a lockdown, too slow to protect the elderly in nursing homes and too slow to build a test and trace system.

Johnson's government says that while it may have made some mistakes it is grappling with the biggest public health crisis since the 1918 influenza outbreak and that it has ensured the health service was not overwhelmed.

Still, the grim death toll surpasses even some projections by the government's own scientific advisers.

In March, Britain's chief scientific adviser said keeping deaths below 20,000 would be a "good outcome". In April, Reuters reported the government's worst-case scenario was 50,000 deaths.

Unlike the daily death toll published by the government, Tuesday's death certificate figures include suspected cases and confirmed cases of Covid-19, the respiratory disease caused by the novel coronavirus.

Epidemiologists say excess mortality - deaths from all causes that exceed the five-year average for the time of year - is the best way of gauging deaths from a disease outbreak because it is internationally comparable.

Some 62,000 more people than usual have died in the UK during this year's coronavirus pandemic, according to the latest available data, an expert from the Office for National Statistics said on Tuesday.

(Reuters)

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less